Clinical Trial Update: Observational Study on Levemir® in Obese Diabetic Patients

View source ↗

Summary

An observational study evaluating Levemir (insulin detemir) in obese patients with diabetes, including type 1 and type 2 diabetes; status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus
• Type 2 Diabetes Mellitus

Drugs mentioned

• Levemir (insulin detemir)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 1 | Status: COMPLETED